• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number T177
Device Problems Over-Sensing (1438); Pacing Problem (1439); Inappropriate/Inadequate Shock/Stimulation (1574); Device Operates Differently Than Expected (2913); Device Sensing Problem (2917); Impedance Problem (2950); Insufficient Information (3190)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/24/2014
Event Type  malfunction  
Event Description
Boston scientific received information that during a routine follow-up, oversensed noise was noted on the right ventricular channel which was stored as high rate ventricular events.This led to the patient receiving four bursts of anti-tachycardia pacing and a shock.A slight fluctuation in pacing impedances were also noted, but no measurements were out of range.The patient's device was later explanted and replaced without any further allegations made against it.No adverse patient effects were reported.
 
Manufacturer Narrative
(b)(4).Upon receipt at our post market quality assurance laboratory, a review of device memory revealed that the device declared elective replacement indicator (eri) after experiencing two charge times greater than the charge time limit.End of life (eol) was declared following a single charge time greater than 30 seconds.The observed rate of battery usage was compared to the expected rate of battery usage and the results indicated the monitoring voltage was normal based on therapy use and programmed settings.It was concluded that this device did not experience premature battery depletion.Rather, the eri to eol time period was shortened due to a higher-than-typical buildup of internal battery impedance.The device was capable of detecting and treating arrhythmias, as the battery itself had sufficient capacity remaining to provide therapy if needed.Analysis was not able to confirm the previous allegations made against this device in the field.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITALITY 2
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 55112
6515824786
MDR Report Key4916679
MDR Text Key20442650
Report Number2124215-2015-09200
Device Sequence Number1
Product Code KRG
Combination Product (y/n)N
PMA/PMN Number
P960040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/16/2008
Device Model NumberT177
Other Device ID NumberVITALITY 2 VR EL
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/03/2015
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 06/17/2015
Initial Date FDA Received07/15/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/18/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
T177; 0165
Patient Age84 YR
-
-